Voriconazole-induced periostitis post transplant: an illustrative review of thoracic computed tomography imaging manifestations

Transplant Infectious Disease : an Official Journal of the Transplantation Society
M RheinboldtR Agarwal

Abstract

Voriconazole, first commercially approved in 2002 as a second-generation antifungal agent, is commonly used in the immunocompromised setting as both a therapeutic and prophylactic agent. Since 2009, scattered case reports and small case series have detailed a secondary drug-related hyperfluorosis-induced painful periostitis that can occur in the treated patient population. We present a pictorial review of the thoracic imaging manifestations utilizing 3 illustrative cases in the setting of both solid organ and bone marrow transplantation. Knowledge of the relatively characteristic radiographic appearance and distribution, when coupled with the appropriate clinical context and associated laboratory findings, is important in narrowing an otherwise relatively broad differential diagnosis.

References

Mar 22, 1990·The New England Journal of Medicine·R Lindsay
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leonard B Johnson, Carol A Kauffman
Oct 23, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·T F WangR Saggar
Jul 24, 2010·Skeletal Radiology·Lina Chen, Michael E Mulligan
Dec 21, 2010·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Asad AyubFergus E McKiernan
Jan 18, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert A WermersThomas P Moyer
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jodi L SkilesMonica L Hulbert
Oct 19, 2011·Antimicrobial Agents and Chemotherapy·George R ThompsonDemosthenes Pappagianis
May 15, 2013·Transplant Infectious Disease : an Official Journal of the Transplantation Society·R TedjaS Gordon
Jan 15, 2014·Journal of Radiology Case Reports·Matthew D BucknorThomas M Link

❮ Previous
Next ❯

Citations

Jul 5, 2016·Clinical Rheumatology·Marwan H Adwan
Nov 8, 2018·AJR. American Journal of Roentgenology·Isaiah TanWinnie Anne Mar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Journal of Nuclear Medicine and Molecular Imaging
Christine RossierAriane Boubaker
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Tetiana Glushko, Inés Colmegna
Journal of Radiology Case Reports
Matthew D BucknorThomas M Link
Transplant Infectious Disease : an Official Journal of the Transplantation Society
D J WojenskiS K Hashmi
© 2021 Meta ULC. All rights reserved